The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism

Gulhane School of Medicine

Status: Completed

Conditions: Idiopathic Hypogonadotropic Hypogonadism

Treatments: Drug: Pregnyl (hCG) ampule 1500 IU/three times a week; Drug: hCG 1500 IU three times a week

Study type: Observational

Funder types: Other

Identifiers

NCT02042638

27122013

Details and patient eligibility

About

Effects of hCG replacement therapy on metabolic syndrome parameters in hypogonadotrophic hypogonadism.

Enrollment: 16 patients

Sex: Male

Ages: 16 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Serum testosterone concentration < 300ng/dL Absence of a pituitary or hypothalamic mass lesions, Presence of gonadotropin response to GnRH, -

Exclusion Criteria: Previous androgen treatment, diabetes mellitus, arterial hypertension other hormone deficiencies

Trial design

16 participants in 1 patient group

16 treatment naive Hypogonadotropic hypogonadism patients

Description:

Treatment naive 16 patients with idiopathic hypogonadotrophic hypogonadism

Treatment:

Drug: hCG 1500 IU three times a week

Drug: Pregnyl (hCG) ampule 1500 IU/three times a week